Filing Flows › Standard Biotools (LAB) › Product revenue
Standard Biotools (LAB) Product revenue by quarter
Standard Biotools' Product revenue was $14.3M in Q3 2026 (third quarter 2026), -1% from Q2 2026. Over the last 6 quarters it ranged from $13.8M (Q3 2025) to $17.4M (Q4 2025).
| Quarter | Product revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $14.3M | -1% | +4% |
| Q2 2026 | $14.5M | -6% | -7% |
| Q1 2026 | $15.5M | -11% | — |
| Q4 2025 | $17.4M | +26% | — |
| Q3 2025 | $13.8M | -12% | — |
| Q2 2025 | $15.7M | — | — |
Q3 2026 at a glance
Standard Biotools, Q3 2026: revenue $19.4M (-0.9% year over year), operating margin -102.0%, net earnings $13.5M, operating cash flow −$6.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Standard Biotools' Product revenue?
Standard Biotools' Product revenue was $14.3M in Q3 2026 (third quarter 2026), -1% from Q2 2026.
How has Standard Biotools' Product revenue changed?
Over the last 6 quarters it ranged from $13.8M (Q3 2025) to $17.4M (Q4 2025).